Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cardiotoxicity × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18 Neoplasms 16 Leukemia, Myeloid, Acute 9 Ovarian Neoplasms 6 Lymphoma 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Glioblastoma 5 Stomach Neoplasms 4 Lung Neoplasms 4 Leukemia 4 Fatigue 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Myelodysplastic Syndromes 3 Motor Activity 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Pain 2

Interventions

Echocardiography 13 Doxorubicin 9 Exercise 8 Electrocardiography 7 Trastuzumab 5 Cyclophosphamide 5 Carvedilol 4 Docetaxel 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Tablets 2 Social Determinants of Health 2 Magnetic Resonance Spectroscopy 2 Ivabradine 2 High-Intensity Interval Training 2 Blood Specimen Collection 2 Bisoprolol 2 Antineoplastic Agents 2 Anthracyclines 2 sulforaphane 1 schizandrin 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 mitoquinone 1 fructus schizandrae, radix ginseng, radix ophiopogonis drug combination 1 epicatechin gallate 1 dapagliflozin 1 candesartan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04598646 2025-12-03

HIMALAYAS-P

University Health Network, Toronto

Phase NA Completed

Behavior, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡